Ledger.Open graph →
SEC Form D · filed March 19, 2014

KOLLTAN PHARMACEUTICALS INC

Offering
$60.0M
Sold
$60.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW HAVEN, CT
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

E. J. Soderstrom · New Haven, CTDirectorAxel G. Bolte · New Haven, CTDirectorPaul J. Medeiros · New Haven, CTDirectorK. P. Hirth · New Haven, CTDirectorStanley P. Choy · New Haven, CTExecYaron P. Hadari · New Haven, CTExecJoseph B. Schlessinger · New Haven, CTDirectorThomas B. Neff · New Haven, CTDirectorArthur G. Altschul, Jr · New Haven, CTDirectorJane P. Henderson · New Haven, CTExecTheresa M. Lavallee · New Haven, CTExecCarolyn F. Sidor · ROCKVILLE, MDExecGerald Mcmahon · New Haven, CTExec · DirectorBrian G. Lancaster · SAN FRANCISCO, CADirectorIlan Weinberg · Darien, CTDirectorPetr Marousek · Darien, CTDirectorJames D. Howard, Jr · Phoenix, AZExecJoseph F. Campagna · Reston, VAExecTC Georgia II LLC · Phoenix, AZDirectorTC Georgia LLC · Phoenix, AZDirectorLeonard S. Polonsky · Douglas, Y8DirectorPaul J. Medeiros · New Haven, CTDirectorTheresa M. Lavallee · New Haven, CTExecCarolyn F. Sidor · New Haven, CTExecGerald Mcmahon · New Haven, CTExec · DirectorJane P. Henderson · New Haven, CTExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗